Photo by nci from unsplash
Drug-eluting stents (DES) remain the most widely used treatment for in-stent restenosis (ISR). In this analysis we sought to determine the proportion, characteristics, and outcomes of patients who do or… Click to show full abstract
Drug-eluting stents (DES) remain the most widely used treatment for in-stent restenosis (ISR). In this analysis we sought to determine the proportion, characteristics, and outcomes of patients who do or do not receive DES for ISR. We included all patients undergoing percutaneous coronary
Keywords:
stent restenosis;
characteristics outcomes;
drug eluting;
patients receive
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!